Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Li-Yan Miao

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
International Journal of Clinical Pharmacology and Therapeutics|August 1, 2015
The genetic polymorphisms of POR*28 and CYP3A5*3 significantly influence the pharmacokinetics of tacrolimus in Chinese renal transplant recipientsJing-Jing Zhang, Shuai-Bing Liu, Ling Xue, et al.
International Journal of Clinical and Experimental Medicine|August 27, 2015
Warfarin dosage adjustment strategy in Chinese populationZhe Yu, Ying-Long Ding, Fei Lu, et al.
The American Journal of the Medical Sciences|September 24, 2014
Population pharmacokinetics and individualized dosage prediction of cyclosporine in allogeneic hematopoietic stem cell transplant patientsLing Xue, Wen-Wen Zhang, Xiao-Liang Ding, et al.
Mediators of Inflammation|November 6, 2015
Therapeutic Effect of Chenodeoxycholic Acid in an Experimental Rabbit Model of OsteoarthritisZhao-wei Yan, Ji Dong, Chen-hao Qin, et al.
Yao Xue Xue Bao = Acta Pharmaceutica Sinica|January 13, 2015
[Population pharmacokinetics and pharmacodynamics of clopidogrel in patients with acute coronary syndrome]Cheng Xie, Xiao-Liang Ding, Ling Xue, et al.
Archives of Cardiovascular Diseases|May 28, 2013
Effects of enalapril on the expression of cardiac angiotensin-converting enzyme and angiotensin-converting enzyme 2 in spontaneously hypertensive ratsZhen Yang, Xin Yu, Li Cheng, et al.
World Journal of Gastrointestinal Oncology|November 24, 2025
Tumour chemotherapy sensitivity test may predict clinical outcomes in colorectal cancer patients receiving oxaliplatin and fluoropyrimidine-based regimensSi-Jia Li, Yi-Xuan Lu, Fang-Yue Zheng, et al.
European Journal of Drug Metabolism and Pharmacokinetics|October 13, 2023
Pharmacokinetics, Mass Balance and Metabolism of [<sup>14</sup>C]HSK21542, a Novel Kappa Opioid Receptor Agonist, in HumansJin-Jie Yuan, Yi-Cong Bian, Sheng Ma, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|December 25, 2012
Efficacy and safety of adjunctive cilostazol to dual antiplatelet therapy after stent implantation: an updated meta-analysis of randomized controlled trialsXiao Liang Ding, Cheng Xie, Bin Jiang, et al.
Clinical Pharmacology in Drug Development|February 28, 2019
Study on Drug-Drug Interactions Between Chiglitazar, a Novel PPAR Pan-Agonist, and Metformin Hydrochloride in Healthy SubjectsLing Yi, Hua Zhang, Jin-Wen Zhang, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
International Journal of Clinical Pharmacology and Therapeutics|August 1, 2015
The genetic polymorphisms of POR*28 and CYP3A5*3 significantly influence the pharmacokinetics of tacrolimus in Chinese renal transplant recipientsJing-Jing Zhang, Shuai-Bing Liu, Ling Xue, et al.
International Journal of Clinical and Experimental Medicine|August 27, 2015
Warfarin dosage adjustment strategy in Chinese populationZhe Yu, Ying-Long Ding, Fei Lu, et al.
The American Journal of the Medical Sciences|September 24, 2014
Population pharmacokinetics and individualized dosage prediction of cyclosporine in allogeneic hematopoietic stem cell transplant patientsLing Xue, Wen-Wen Zhang, Xiao-Liang Ding, et al.
Mediators of Inflammation|November 6, 2015
Therapeutic Effect of Chenodeoxycholic Acid in an Experimental Rabbit Model of OsteoarthritisZhao-wei Yan, Ji Dong, Chen-hao Qin, et al.
Yao Xue Xue Bao = Acta Pharmaceutica Sinica|January 13, 2015
[Population pharmacokinetics and pharmacodynamics of clopidogrel in patients with acute coronary syndrome]Cheng Xie, Xiao-Liang Ding, Ling Xue, et al.
Archives of Cardiovascular Diseases|May 28, 2013
Effects of enalapril on the expression of cardiac angiotensin-converting enzyme and angiotensin-converting enzyme 2 in spontaneously hypertensive ratsZhen Yang, Xin Yu, Li Cheng, et al.
World Journal of Gastrointestinal Oncology|November 24, 2025
Tumour chemotherapy sensitivity test may predict clinical outcomes in colorectal cancer patients receiving oxaliplatin and fluoropyrimidine-based regimensSi-Jia Li, Yi-Xuan Lu, Fang-Yue Zheng, et al.
European Journal of Drug Metabolism and Pharmacokinetics|October 13, 2023
Pharmacokinetics, Mass Balance and Metabolism of [<sup>14</sup>C]HSK21542, a Novel Kappa Opioid Receptor Agonist, in HumansJin-Jie Yuan, Yi-Cong Bian, Sheng Ma, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|December 25, 2012
Efficacy and safety of adjunctive cilostazol to dual antiplatelet therapy after stent implantation: an updated meta-analysis of randomized controlled trialsXiao Liang Ding, Cheng Xie, Bin Jiang, et al.
Clinical Pharmacology in Drug Development|February 28, 2019
Study on Drug-Drug Interactions Between Chiglitazar, a Novel PPAR Pan-Agonist, and Metformin Hydrochloride in Healthy SubjectsLing Yi, Hua Zhang, Jin-Wen Zhang, et al.
Pageof 4